Trials / Withdrawn
WithdrawnNCT03597386
ConfirmMDx Assay in Multiparametric MRI (mpMRI) PIRADS Scored Lesions After a Negative MR/US Fusion Biopsy
ConfirmMDx Assay is Multiparametric MRI (mpMRI) PIRADS Scored Lesions After a Negative MR/US Fusion Biopsy
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- Male
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if the ConfirmMDx assay is useful in finding prostate cancer in patients who are at increased risk for prostate cancer based on elevated PSA and prostate lesion identified on mpMRI.
Conditions
Timeline
- Start date
- 2019-01-23
- Primary completion
- 2019-01-24
- Completion
- 2019-01-24
- First posted
- 2018-07-24
- Last updated
- 2019-03-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03597386. Inclusion in this directory is not an endorsement.